Trial intelligence / Profile preview

Exosome Proteomics to Detect EPO Use

NCT03700515Unknown

Start
Sep 2019
Primary completion
Oct 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of erythropoietin in anemia (3 arms). Primary endpoint: Blood proteome enrichment pathway analysis in GO annotation at Week 3. Status: unknown.

02

Drugs

erythropoietin
03

Conditions

anemia

Beyond the preview

Go deeper on NCT03700515.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03700515.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call